These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 2993609)

  • 21. Synthesis, opioid receptor binding, and bioassay of naltrindole analogues substituted in the indolic benzene moiety.
    Ananthan S; Johnson CA; Carter RL; Clayton SD; Rice KC; Xu H; Davis P; Porreca F; Rothman RB
    J Med Chem; 1998 Jul; 41(15):2872-81. PubMed ID: 9667975
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Correlation between circular dichroism data and biological activities of 2,5 substituted enkephalin analogues.
    Soós J; Berzétei I; Bajusz S; Rónai AZ
    Life Sci; 1980 Jul; 27(2):129-33. PubMed ID: 6249995
    [No Abstract]   [Full Text] [Related]  

  • 23. Binaltorphimine and nor-binaltorphimine, potent and selective kappa-opioid receptor antagonists.
    Portoghese PS; Lipkowski AW; Takemori AE
    Life Sci; 1987 Mar; 40(13):1287-92. PubMed ID: 2882399
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diprenorphine has agonist activity at opioid kappa-receptors in the myenteric plexus of the guinea-pig ileum.
    Traynor JR; Corbett AD; Kosterlitz HW
    Eur J Pharmacol; 1987 May; 137(1):85-9. PubMed ID: 3038579
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Activities of morphinone and N-(cyclopropylmethyl)normorphinone at opioid receptors.
    Fang S; Takemori AE; Portoghese PS
    J Med Chem; 1984 Oct; 27(10):1361-3. PubMed ID: 6207298
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The mu-opioid activity of kappa-opioid receptor agonist compounds in the guinea pig ileum.
    Berzetei-Gurske IP; Toll L
    Eur J Pharmacol; 1992 Mar; 212(2-3):283-6. PubMed ID: 1318215
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Determination of the receptor selectivity of opioid agonists in the guinea-pig ileum and mouse vas deferens by use of beta-funaltrexamine.
    Hayes AG; Sheehan MJ; Tyers MB
    Br J Pharmacol; 1985 Dec; 86(4):899-904. PubMed ID: 3000501
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diastereomeric 6-desoxy-6-spiro-alpha-methylene-gamma-butyrolactone derivatives of naltrexone and oxymorphone. Selective irreversible inhibition of naltrexone binding in an opioid receptor preparation by a conformationally restricted michael acceptor ligand.
    Koolpe GA; Nelson WL; Gioannini TL; Angel L; Simon EJ
    J Med Chem; 1984 Dec; 27(12):1718-23. PubMed ID: 6209395
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A selective delta 1 opioid receptor agonist derived from oxymorphone. Evidence for separate recognition sites for delta 1 opioid receptor agonists and antagonists.
    Portoghese PS; Moe ST; Takemori AE
    J Med Chem; 1993 Aug; 36(17):2572-4. PubMed ID: 8394935
    [No Abstract]   [Full Text] [Related]  

  • 30. Irreversible opiate agonists and antagonists: the 14-hydroxydihydromorphinone azines.
    Hahn EF; Carroll-Buatti M; Pasternak GW
    J Neurosci; 1982 May; 2(5):572-6. PubMed ID: 6176696
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evidence for coupling of the kappa opioid receptor to brain GTPase.
    Clark MJ; Levenson SD; Medzihradsky F
    Life Sci; 1986 Nov; 39(19):1721-7. PubMed ID: 3022093
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Absence of conditioned place preference or reinstatement with bivalent ligands containing mu-opioid receptor agonist and delta-opioid receptor antagonist pharmacophores.
    Lenard NR; Daniels DJ; Portoghese PS; Roerig SC
    Eur J Pharmacol; 2007 Jul; 566(1-3):75-82. PubMed ID: 17383633
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Binaltorphimine-related bivalent ligands and their kappa opioid receptor antagonist selectivity.
    Portoghese PS; Nagase H; Lipkowski AW; Larson DL; Takemori AE
    J Med Chem; 1988 Apr; 31(4):836-41. PubMed ID: 2832604
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Opioid agonist and antagonist activities of monofunctional nitrogen mustard analogues of beta-chlornaltrexamine.
    Schoenecker JW; Takemori AE; Portoghese PS
    J Med Chem; 1987 May; 30(5):933-5. PubMed ID: 3033246
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Investigation of the structural requirements for the kappa-selective opioid receptor antagonist, 6 beta,6 beta'-[ethylenebis(oxyethyleneimino)]bis[17-(cyclopropylmethyl)- 4,5 alpha-epoxymorphinan-3,14-diol] (TENA).
    Botros S; Lipkowski AW; Takemori AE; Portoghese PS
    J Med Chem; 1986 May; 29(5):874-6. PubMed ID: 3009817
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis and biological activity of beta-endorphin and analogues. Additional evidence for multiple opiate receptors.
    Lemaire S; Bérubé A; Derome G; Lemaire I; Magnan J; Regoli D; St Pierre S
    J Med Chem; 1978 Dec; 21(12):1232-5. PubMed ID: 214559
    [No Abstract]   [Full Text] [Related]  

  • 37. Hybrid bivalent ligands with opiate and enkephalin pharmacophores.
    Portoghese PS; Larson DL; Ronsisvalle G; Schiller PW; Nguyen TM; Lemieux C; Takemori AE
    J Med Chem; 1987 Nov; 30(11):1991-4. PubMed ID: 2444704
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Allylprodine analogues as receptor probes. Evidence that phenolic and nonphenolic ligands interact with different subsites on identical opioid receptors.
    Portoghese PS; Alreja BD; Larson DL
    J Med Chem; 1981 Jul; 24(7):782-7. PubMed ID: 6268787
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Opioid agonist and antagonist bivalent ligands. The relationship between spacer length and selectivity at multiple opioid receptors.
    Portoghese PS; Larson DL; Sayre LM; Yim CB; Ronsisvalle G; Tam SW; Takemori AE
    J Med Chem; 1986 Oct; 29(10):1855-61. PubMed ID: 3020244
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A novel opioid receptor site directed alkylating agent with irreversible narcotic antagonistic and reversible agonistic activities.
    Portoghese PS; Larson DL; Sayre LM; Fries DS; Takemori AE
    J Med Chem; 1980 Mar; 23(3):233-4. PubMed ID: 6245210
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.